<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04930172</url>
  </required_header>
  <id_info>
    <org_study_id>TORCH2</org_study_id>
    <nct_id>NCT04930172</nct_id>
  </id_info>
  <brief_title>TOtal tRansfemoral branCHed endovasCular tHoracoabdominal Aortic Repair Registry</brief_title>
  <official_title>A Physician-initiated, National, Multicentre, Ambispective, Observational Registry of Patients Undergoing Branched Endovascular Aortic Procedures With a Total Transfemoral Approach. (TORCH2 Registry)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Azienda Sanitaria Universitaria Giuliano Isontina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>IRCCS San Raffaele</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the registry is to evaluate the peri-operative, short-, and mid- outcomes of&#xD;
      endovascular treatment of thoracoabdominal aneurysms with multibranched endografts via total&#xD;
      transfemoral approach for visceral vessels cannulation using steerable sheaths&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 30, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>technical success</measure>
    <time_frame>30 days</time_frame>
    <description>successful bridging stent graft deployment of all vessels, with aneurysm exclusion, without any signs of type I or type III endoleak, and with no evidence of stenosis/occlusion and mating stent dislocation/kinking at intraoperative completion angiography.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>branch instability</measure>
    <time_frame>30 days</time_frame>
    <description>freedom from any branch related complications and/or required reinterventions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>clinical success</measure>
    <time_frame>30 days</time_frame>
    <description>absence of death, type I/III endoleak, graft infection/thrombosis, aneurysm expansion and/or rupture, conversion to open repair, or new treatment-related thoracoabdominal pathologies</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Aortic Aneurysm, Abdominal</condition>
  <condition>Aortic Aneurysm, Thoracic</condition>
  <arm_group>
    <arm_group_label>Steerable introducers</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Steerable introducers</intervention_name>
    <description>endografts via total transfemoral approach for visceral vessels cannulation</description>
    <arm_group_label>Steerable introducers</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The Registry will include approximately 100 patients treated with BEVAR from January 2018&#xD;
        to January 2022 for thoracoabdominal aortic aneurysms with total transfemoral procedures&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient adult ( ≥18 years) of either sex,&#xD;
&#xD;
          -  patients who underwent a complex aortic procedure requiring a branched endograft via&#xD;
             total transfemoral approach in the centers involved in the TORCH2 Registry&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients who did not receive treatment via total transfemoral approach,&#xD;
&#xD;
          -  patient with bleeding diathesis or coagulopathy,&#xD;
&#xD;
          -  patients with active systemic or cutaneous infection or inflammation,&#xD;
&#xD;
          -  patients who are pregnant or lactating,&#xD;
&#xD;
          -  patient younger than 18 years of age.&#xD;
&#xD;
          -  Absence of at least one imaging follow-up within the first post-operative year&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Luca Bertoglio, MD</last_name>
    <phone>+390226437381</phone>
    <email>bertoglio.luca@hsr.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mario D'Oria, MD</last_name>
    <email>mario.doria@asugi.sanita.fvg.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IRCCS Ospedale San Raffaele</name>
      <address>
        <city>Milano</city>
        <state>Lombardia</state>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Luca Bertoglio, MD</last_name>
      <email>bertoglio.luca@hsr.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico S. Orsola Malpighi</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Mauro Gargiulo</last_name>
      <email>mauro.gargiulo2@unibo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Universitaria Giuliano Isontina</name>
      <address>
        <city>Cattinara</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Sandro Lepidi, Prof.</last_name>
      <email>sandro.lepidi@asugi.sanita.fvg.it</email>
    </contact>
    <contact_backup>
      <last_name>Mario D'Oria, MD</last_name>
      <email>mario.doria@asugi.sanita.fvg.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ospedale Policlinico San Martino</name>
      <address>
        <city>Genova</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Giovanni Pratesi, MD</last_name>
      <email>giovanni.pratesi@unige.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Perugia</name>
      <address>
        <city>Perugia</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Giambattista Parlani, MD</last_name>
      <email>parlani.gianbattista@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale San Camillo-Forlanini</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Nicola Mangialardi, MD</last_name>
      <email>nikmangialardi@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale San Giovanni Addolorata</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Rocco Giudice</last_name>
      <email>rgiudice@hsangiovanni.roma.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Mirza AK, Tenorio ER, Kärkkäinen JM, Hofer J, Macedo T, Cha S, Ozbek P, Oderich GS. Learning curve of fenestrated and branched endovascular aortic repair for pararenal and thoracoabdominal aneurysms. J Vasc Surg. 2020 Aug;72(2):423-434.e1. doi: 10.1016/j.jvs.2019.09.046. Epub 2020 Feb 17.</citation>
    <PMID>32081482</PMID>
  </reference>
  <reference>
    <citation>Tenorio ER, Oderich GS, Farber MA, Schneider DB, Timaran CH, Schanzer A, Beck AW, Motta F, Sweet MP; U.S. Fenestrated and Branched Aortic Research Consortium Investigators. Outcomes of endovascular repair of chronic postdissection compared with degenerative thoracoabdominal aortic aneurysms using fenestrated-branched stent grafts. J Vasc Surg. 2020 Sep;72(3):822-836.e9. doi: 10.1016/j.jvs.2019.10.091. Epub 2019 Dec 25.</citation>
    <PMID>31882309</PMID>
  </reference>
  <reference>
    <citation>Oikonomou K, Kopp R, Katsargyris A, Pfister K, Verhoeven EL, Kasprzak P. Outcomes of fenestrated/branched endografting in post-dissection thoracoabdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2014 Dec;48(6):641-8. doi: 10.1016/j.ejvs.2014.07.005. Epub 2014 Aug 28.</citation>
    <PMID>25176618</PMID>
  </reference>
  <reference>
    <citation>Motta F, Parodi FE, Knowles M, Crowner JR, Pascarella L, McGinigle KL, Marston WA, Kibbe MR, Ohana E, Farber MA. Performance of Viabahn balloon-expandable stent compared with self-expandable covered stents for branched endovascular aortic repair. J Vasc Surg. 2021 Feb;73(2):410-416.e2. doi: 10.1016/j.jvs.2020.05.028. Epub 2020 May 27.</citation>
    <PMID>32473341</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 11, 2021</study_first_submitted>
  <study_first_submitted_qc>June 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2021</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS San Raffaele</investigator_affiliation>
    <investigator_full_name>Bertoglio Luca</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
    <mesh_term>Aortic Aneurysm, Thoracic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

